Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference

EMERYVILLE, Calif., Sept. 8, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual...

Click to view original post